4.5 Article

Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design

Michael D. Huband et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)

Article Microbiology

Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases

Tsukasa Ito-Horiyama et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

Letter Infectious Diseases

Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli

Laurent Poirel et al.

LANCET INFECTIOUS DISEASES (2016)

Letter Infectious Diseases

Co-occurrence of extended spectrum β lactamase and MCR-1 encoding genes on plasmids

Marisa Haenni et al.

LANCET INFECTIOUS DISEASES (2016)

Article Immunology

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Neil Gupta et al.

CLINICAL INFECTIOUS DISEASES (2011)

Review Infectious Diseases

Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern

Johann D. D. Pitout et al.

LANCET INFECTIOUS DISEASES (2008)

Review Immunology

Bacterial resistance: Origins, epidemiology, and impact

DM Livermore

CLINICAL INFECTIOUS DISEASES (2003)